Till startsida
To content Read more about how we use cookies on gu.se

Global antibiotic resistance

Open to the public

International symposium about the recent development of microbes that are developing a resistance to antibiotics reducing the effectiveness in such drugs and leading to greater risk of prlonged illness and greater risk of death.

The symposium is held in English.

Since their discovery during the 1940s and onwards, antimicrobial agents (antibiotics and related medicinal drugs) have substantially reduced the threat posed by infectious diseases. The use of these "wonder drugs", combined with improvements in sanitation, housing, and nutrition, and the advent of wide­spread immunization programmes, has led to a dramatic drop in deaths from diseases that were previously widespread, untreatable, and frequently fatal. Over the years, antimicro­bials have saved the lives and eased the suffering of millions of people. By helping to bring many serious infectious dis­eases under control, these drugs have also contributed to the major gains in life expectancy experienced during the latter part of the last century.

These gains are now seriously jeopardized by another recent development: the emergence and spread of microbes that are resistant to cheap and effective first-choice, or "first-line" drugs. The bacterial infections which contribute most to human disease are also those in which emerging and microbial resistance is most evident: diarrhoeal diseases, respira­tory tract infections, meningitis, sexually transmitted infec­tions, and hospital-acquired infections. Some important ex­amples include penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Sta­phylococcus aureus, multi-resistant salmonellae, and multi-resistant Mycobacterium tuberculosis. The development of resistance to drugs commonly used to treat malaria is of particular con­cern, as is the emerging resistance to anti-HIV drugs.

The consequences are severe. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. Treatment failures also lead to longer periods of infectivity, which increase the numbers of infected people moving in the community and thus expose the general population to the risk of contracting a resistant strain of infection.

This event is part of Global Week - www.globalweek.gu.se

Lecturer: Andreas Heddini MD, PhD (JA) ReAct - Action on Antibiotic Resistance och Swedish Institute for Infectious Disease Control (SMI)
Leif Dotevall, MD, Regional Medical Officer, Department of Communicable Disease Control
Joakim Larsson PhD, assoc prof., The Sahlgrenska Academy at the University of Gothenburg

Date: 11/18/2010

Time: 1:00 PM - 3:45 PM

Categories: Medicine

Organizer: Unit of Social Medicine and the Internationalisation Council at the Sahlgrenska Academy

Location: Medicinareberget, Medicinaregatan 1-11
Lecture hall Ivan Östholm, Medicinaregatan 13

Event URL: Read more about Global antibiotic resistance

Contact person: Gunilla Krantz

Phone: +46 (0)31 786 6861

Page Manager: Helena Åberg|Last update: 10/1/2015

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?